SJS Investment Consulting’s Mesoblast MESO Stock Holding History

SJS Investment Consulting’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-48	Closed	-$600	–	1618
2025 Q1	$600	Sell	48 -47	-49%	-$774	﹤0.01%	1183
2024 Q4	$1.88K	Buy	+95	New	+$1.05K	﹤0.01%	727

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SJS Investment Consulting's MESO Position: Q2 2025 in Review

SJS Investment Consulting sold out of Mesoblast (MESO) in Q2 2025, closing a stake of 48 shares — an estimated $600 sold.

SJS Investment Consulting first reported a position in MESO in Q4 2024 and held it in 2 quarters. The position peaked at $1.88K in Q4 2024. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2025.

SJS Investment Consulting reported no remaining Mesoblast position as of Q2 2025 after selling out during the quarter.
SJS Investment Consulting sold 48 Mesoblast shares in Q2 2025, an estimated $600.
SJS Investment Consulting first reported a position in Mesoblast in Q4 2024 and held it in 2 quarters.
SJS Investment Consulting's Mesoblast position peaked at $1.88K in Q4 2024.
72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2025.

Based on SJS Investment Consulting's 13F filing for Q2 2025, filed 15 Jul 2025.